Conference Reports for NATAP

The International Liver Congress™ EASL - European Association for the Study of the Liver June 22-26 2022 Back

ABI-4334, a novel inhibitor of hepatitis B virus core protein, promotes formation of empty capsids and prevents cccDNA formation by disruption of incoming capsids       EASL 2022 June 22-26 London   Nuruddin Unchwaniwala, William Delaney, Kathryn M Kitrinos   Assembly Biosciences, Inc., South San Francisco, CA, USA